Health Products

Atellica

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Medical devices - Cardiovascular, Health products - Medical devices - Chemistry
Product: Atellica
Issue: Medical devices - Inaccurate test or measurement results
What to do: Contact the manufacturer if you require additional information.
Audience: General public, Health professionals, Hospitals
Recall class: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Affected ProductsLot or Serial NumberModel or catalog number
Advia Centaur Cp System - Enhanced Estradiol (Ee2) AssayAll lots.10490889, 10491445
Atellica Im Enhanced Estradiol (Ee2)All lots.10995562, 10995561
Advia Centaur System - Enhanced Estradiol (Ee2) AssayAll lots.10490889, 10491445

Issue

Siemens Healthcare Diagnostics Inc. has confirmed customer observations of falsely elevated results when using plasma specimens across the entire analytical measuring range (AMR) with the Atellica IM enhanced estradiol (EE2) assay. Results demonstrate that plasma specimens are not meeting claims as defined in the instructions for use (IFU). limited data is available at this time as the investigation for this issue is on-going.

Recall start date: Mar 9, 2022

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime